ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,471Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 910

$805K Total Retail Price of All Prescriptions

Rank: 41 out of 910

903 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 903 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

9% of this provider’s 903 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 11,327 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
SIMVASTATIN 827 752 1 3
LEVOTHYROXINE SODIUM 572 500 2 1
LISINOPRIL 389 351 3 2
AMLODIPINE BESYLATE 389 374 3 4
OMEPRAZOLE 354 319 5 5
ATENOLOL 325 291 6 10
HYDROCODONE-ACETAMINOPHEN 303 268 S3 7 8
LOSARTAN POTASSIUM 303 288 7 15
METFORMIN HCL 283 272 9 6
ZOLPIDEM TARTRATE 261 231 10 17
TRAMADOL HCL 259 229 11 25
METOPROLOL SUCCINATE 193 177 12 21
HYDROCHLOROTHIAZIDE 169 155 13 12
ATORVASTATIN CALCIUM 160 152 14 14
WARFARIN SODIUM 157 153 15 11
GABAPENTIN 149 126 16 13
FUROSEMIDE 147 124 17 9
TAMSULOSIN HCL 131 130 18 29
PRAVASTATIN SODIUM 129 125 19 16
CLOPIDOGREL 125 115 20 35
POTASSIUM CHLORIDE 120 108 21 18
SERTRALINE HCL 118 96 22 24
LOSARTAN-HYDROCHLOROTHIAZIDE 116 104 23 79
ALENDRONATE SODIUM 113 105 24 22
METOPROLOL TARTRATE 111 109 25 7
MELOXICAM 111 92 25 76
CRESTOR 110 97 27 26
GLIPIZIDE ER 106 106 28 87
PANTOPRAZOLE SODIUM 105 91 29 27
TRIAMTERENE-HCTZ 104 96 30 39
GLIPIZIDE XL 104 104 30 108
ALLOPURINOL 103 93 32 33
LANTUS 97 71 33 30
AZITHROMYCIN 91 86 34 41
DIOVAN 89 83 35 34
AMITRIPTYLINE HCL 88 83 R 36 72
PLAVIX 86 79 37 53
PROAIR HFA 83 68 38 40
GEMFIBROZIL 81 72 39 63
BENAZEPRIL HCL 78 75 40 89
TRAZODONE HCL 78 61 40 37
PAROXETINE HCL 75 61 42 50
CIPROFLOXACIN HCL 73 71 43 48
LOVASTATIN 72 60 44 20
CELEBREX 70 70 45 85
SPIRONOLACTONE 67 60 46 66
FLUTICASONE PROPIONATE 66 58 47 23
PEN NEEDLE 65 60 48 124
PREDNISONE 63 62 49 43
INSULIN SYRINGE 59 42 50 47
GLYBURIDE 59 57 R 50 46
HUMALOG 58 53 52 128
SYNTHROID 57 57 53 54
LANTUS SOLOSTAR 57 54 53 112
FLUOXETINE HCL 56 44 55 49
OXYBUTYNIN CHLORIDE ER 54 42 56 111
DILTIAZEM 24HR CD 52 52 57 163
CARVEDILOL 51 48 58 36
VERAPAMIL ER 50 49 59 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.